Methods for treating gastro-esophageal reflux disease and emesis

Details Methods for treating gastro-esophageal reflux disease and emesis Methods for treating gastro-esophageal reflux disease and emesis

1993-10-12

1997-04-08

Cintins, Marianne M.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

A61K 31445

Patent

active

056188285

ABSTRACT:
Methods are disclosed utilizing the optically pure (-) isomer of cisapride. This compound is a potent drug for the treatment of gastro-esophageal reflux disease while substantially reducing the concomitant liability of adverse effects associated with the racemic mixture of cisapride. This compound is also useful in treating or preventing emesis while substantially reducing adverse effects associated with racemic cisapride.

REFERENCES:
patent: 4962115 (1990-10-01), Van Daele
patent: 5057525 (1991-10-01), Van Daele
patent: 5114714 (1992-05-01), Young et al.
patent: 5114715 (1992-05-01), Young et al.
Jamali, F., "Enantioselective Aspects of Drug Action and Disposition: Therapeutic Pitfalls," Journal of Pharmaceutical Sciences 78(9): 695-715 (1989).
Dumuis et al., "The gastrointestinal prokinetic benzamide derivatives are agonists at the non-classical 5-HT receptor (5-HT.sub.4) positively coupled to adenylate cyclase in neurons," Naunyn-Schmiedeberg's Arch Pharmacol 340: 403-410 (1989).
Scrip's New Product Review No. 32 Cisapride, PJB Publications Ltd. (Apr. 1989).
Barone et al., "Bioavailability of Three Oral Dosage Forms of Cisapride, a Gastrointestinal Stimulant Agent," Clinical Pharmacy 6: 640-645 (1987).
Stacher et al., "Effects of Oral Cisapride on Interdigestive Jejunal Motor Activity, Psychomotor Function, and Side-Effect Profile in Healthy Man," Digestive Disease and Sciences, 32(11): 1223-1230 (1987).
Nemeth, P.R., "Gastrointestinal motility stimulating drugs and 5-HT receptors or Myenteric Neurons", Eur. J. Pharmacol. 166: 387-391 (1989).
Schapira, M., et al., "The Current Status of Gastric Prokinetic Drugs", Acta Gastro-Enterologica Belgica, vol. 53 pp. 446-457 (1990).
Gullikson, G.W. et al., "Relationship of Serotonin-3 Receptor Antagonist Activity to Gastric Emptying and Motor-Stimulating Actions of Prokinotic Drugs in Dogs", J. Pharmacol. Experimen. Therp. 258(1): 103-110 (1991).
Nemeth et al., Chemical Abstracts, vol. 111, No. 19, abstract 167161a, 1989 .

Affiliated with

Also associated with

Rating

Methods for treating gastro-esophageal reflux disease and emesis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for treating gastro-esophageal reflux disease and emesis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for treating gastro-esophageal reflux disease and emesis will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2398020